XSHE
002166
Market cap771mUSD
Oct 09, Last price
7.30CNY
1D
4.89%
1Q
15.14%
Jan 2017
-30.98%
IPO
52.32%
Name
Guilin Layn Natural Ingredients Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Guilin Layn Natural Ingredients Corp., established in 1995 and headquartered in Shanghai, China, is a global producer and supplier of plant-derived ingredients. The company specializes in natural sweeteners, flavors, and botanicals, offering a diverse portfolio that includes stevia (extracted from plant leaves), monk fruit extract (sourced from the fruit), and Lovia. Beyond these, their offerings extend to natural flavoring agents, functional ingredients, and nutraceuticals. Guilin Layn also provides a range of ingredients for the food and beverage sector and manufactures animal and pet nutrition products, notably under its TruGro brand.
Key people
Yongfu Xie
Chairman of the Board, General Manager · since 2024
Yu Bai
Deputy General Manager, Director
Huayang Luo
Secretary of the Board, Deputy General Manager · since 2011
Hui Zheng
Chief Financial Officer, Deputy General Manager, Director · since 2025
Xinzhong Zhou
Director · since 2024
Lei Li
Independent Director · since 2023
Hongyu Liu
Independent Director · since 2023
Ruochen Wang
Independent Director · since 2023
Headquarters & legal address
临桂区人民南路19号
桂林市, GX 541199
CN
桂林市, GX 541199
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||